ProShare Advisors LLC reduced its position in Atrion Corporation (NASDAQ:ATRI) by 5.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,084 shares of the medical instruments supplier’s stock after selling 786 shares during the period. ProShare Advisors LLC owned about 0.71% of Atrion Corporation worth $8,417,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in ATRI. Neuberger Berman Group LLC increased its position in shares of Atrion Corporation by 7.4% in the second quarter. Neuberger Berman Group LLC now owns 82,894 shares of the medical instruments supplier’s stock worth $53,326,000 after acquiring an additional 5,695 shares in the last quarter. Prudential Financial Inc. increased its position in shares of Atrion Corporation by 583.6% in the second quarter. Prudential Financial Inc. now owns 4,970 shares of the medical instruments supplier’s stock worth $3,197,000 after acquiring an additional 4,243 shares in the last quarter. Ameriprise Financial Inc. increased its position in shares of Atrion Corporation by 600.4% in the second quarter. Ameriprise Financial Inc. now owns 3,383 shares of the medical instruments supplier’s stock worth $2,177,000 after acquiring an additional 2,900 shares in the last quarter. Old Mutual Global Investors UK Ltd. increased its position in shares of Atrion Corporation by 1,235.0% in the second quarter. Old Mutual Global Investors UK Ltd. now owns 1,068 shares of the medical instruments supplier’s stock worth $687,000 after acquiring an additional 988 shares in the last quarter. Finally, Nationwide Fund Advisors increased its position in shares of Atrion Corporation by 35.9% in the second quarter. Nationwide Fund Advisors now owns 2,966 shares of the medical instruments supplier’s stock worth $1,908,000 after acquiring an additional 784 shares in the last quarter. 59.72% of the stock is currently owned by institutional investors and hedge funds.

In other news, Chairman Emile A. Battat sold 1,408 shares of the company’s stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $652.91, for a total value of $919,297.28. Following the completion of the sale, the chairman now directly owns 148,881 shares of the company’s stock, valued at approximately $97,205,893.71. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 24.23% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.watchlistnews.com/proshare-advisors-llc-has-8-42-million-stake-in-atrion-corporation-atri/1573205.html.

Atrion Corporation (NASDAQ:ATRI) traded down 0.11% on Tuesday, hitting $656.75. 437 shares of the stock traded hands. The stock has a market capitalization of $1.22 billion, a P/E ratio of 36.80 and a beta of 0.91. The company’s 50 day moving average price is $636.97 and its 200-day moving average price is $567.17. Atrion Corporation has a 12-month low of $405.93 and a 12-month high of $691.95.

Atrion Corporation (NASDAQ:ATRI) last announced its quarterly earnings results on Tuesday, August 8th. The medical instruments supplier reported $5.40 EPS for the quarter. The company had revenue of $36.16 million during the quarter. Atrion Corporation had a return on equity of 18.67% and a net margin of 22.75%. Analysts predict that Atrion Corporation will post $9.90 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 15th will be paid a $1.20 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This is a boost from Atrion Corporation’s previous quarterly dividend of $1.05. This represents a $4.80 dividend on an annualized basis and a dividend yield of 0.73%. Atrion Corporation’s dividend payout ratio is 26.88%.

Separately, BidaskClub downgraded shares of Atrion Corporation from a “strong-buy” rating to a “buy” rating in a research report on Thursday, July 27th.

Atrion Corporation Company Profile

Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.

Want to see what other hedge funds are holding ATRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atrion Corporation (NASDAQ:ATRI).

Institutional Ownership by Quarter for Atrion Corporation (NASDAQ:ATRI)

Receive News & Ratings for Atrion Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.